首页> 外文OA文献 >PIN29 A Dynamic Health Economics App: The Budget Impact Of Adopting The Recently Fda Approved Hepatitis C Therapy, Sofosbuvir To A United States Formulary

【2h】

PIN29 A Dynamic Health Economics App: The Budget Impact Of Adopting The Recently Fda Approved Hepatitis C Therapy, Sofosbuvir To A United States Formulary

机译：PIN29动态卫生经济学应用程序：采用Fda批准的丙型肝炎治疗新药Sofosbuvir对美国处方药的预算影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Lingohr-Smith M.; Lin J.;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cost-Effectiveness and Budget Impact of Hepatitis C Virus Treatment With Sofosbuvir and Ledipasvir in the United States [J] . Chhatwal Jagpreet, Kanwal Fasiha, Roberts Mark S., Annals of Internal Medicine . 2015,第6期

机译：在美国使用Sofosbuvir和Ledipasvir治疗C型肝炎病毒的成本效益和预算影响
2. Cost-Effectiveness and Budget Impact of Hepatitis C Virus Treatment With Sofosbuvir and Ledipasvir in the United States [J] . Chhatwal Jagpreet, Kanwal Fasiha, Roberts Mark S., Annals of Internal Medicine . 2015,第6期

机译：在美国使用Sofosbuvir和Ledipasvir治疗C型肝炎病毒的成本效益和预算影响
3. Current FDA-Related Drug Information New Drugs Approved by the FDA New Dosage Forms and Indications Approved by the FDA Agents Pending FDA Approval New Drug/Biologies License Applications Filed by Manufacturer Supplemental Applications Filed by Manufacturer Significant Labeling Changes or "Dear Health Professional" Letters Related to Safety [J] . Danial E. Baker Hospital pharmacy. . 2010,第6期

机译：当前与FDA有关的药物信息由FDA批准的新药物，由FDA代理商批准的新剂型和适应症，待FDA批准的制造商提出的新药/生物许可申请，制造商提出的补充申请，重要的标签变更或与“亲爱的健康专业人员”的信件安全
4. Dose enhancement during concomitant chemoradiotherapy using FDA approved concentrations of carboplatin and oxaliplatin nanoparticles [C] . Gizem Cifter, Yucel Altundal, Alex Detappe World Congress on Medical Physics and Biomedical Engineering . 2015

机译：使用FDA批准的Carboplatin和Oxaliplatin纳米粒子伴随的伴随化学疗法期间的剂量增强
5. Innovation Attributes and Electronic Word-of-Mouth: Impact on Likelihood to Adopt Health Apps and Health Behaviors [D] . Chapman, Paige Renee Madsen. 2018

机译：创新属性和电子口碑：对采用健康应用程序和健康行为的可能性的影响
6. Cost-Effectiveness and Budget Impact of Hepatitis C Virus Treatment With Sofosbuvir and Ledipasvir in the United States [O] . Jagpreet Chhatwal, Fasiha Kanwal, Mark S. Roberts, -1

机译：在美国使用Sofosbuvir和Ledipasvir治疗C型肝炎病毒的成本效益和预算影响
7. PIN8 The Economic Impact of Adding Ceftaroline Fosamil to Hospital Formulary for Community Acquired Bacterial Pneumonia: A Hospital Budget Impact Analysis in the United States [O] . Huang X.Y., Lodise T., Friedland D., 2012

机译：PIN8对社区获得性细菌性肺炎在医院处方中添加头孢洛林福沙米尔的经济影响：美国的医院预算影响分析
8. CB2 Receptor Therapy Using the FDA-Approved Drug Raloxifene to Mitigate Visual Deficits after Mild TBI and/or Ocular Trauma. [R] . Reiner , A. 2018

机译：CB2受体治疗使用FDa批准的药物雷洛昔芬缓解轻度TBI和/或眼部创伤后的视力缺陷。

PIN29 A Dynamic Health Economics App: The Budget Impact Of Adopting The Recently Fda Approved Hepatitis C Therapy, Sofosbuvir To A United States Formulary

著录项

引文网络

相似文献

相关主题

期刊订阅